UnitedHealth Group Incorporated (NYSE:UNH) Position Maintained by Catalyst Capital Advisors LLC

Catalyst Capital Advisors LLC continued to hold its stake in UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,400 shares of the healthcare conglomerate’s stock at the end of the first quarter. Catalyst Capital Advisors LLC’s holdings in UnitedHealth Group were worth $230,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Jackson Grant Investment Advisers Inc. raised its stake in UnitedHealth Group by 0.4% in the fourth quarter. Jackson Grant Investment Advisers Inc. now owns 1,093 shares of the healthcare conglomerate’s stock valued at $175,000 after buying an additional 4 shares in the last quarter. Adirondack Trust Co. raised its stake in UnitedHealth Group by 0.5% in the first quarter. Adirondack Trust Co. now owns 990 shares of the healthcare conglomerate’s stock valued at $162,000 after buying an additional 5 shares in the last quarter. Paradigm Financial Advisors LLC raised its stake in UnitedHealth Group by 0.4% in the first quarter. Paradigm Financial Advisors LLC now owns 2,761 shares of the healthcare conglomerate’s stock valued at $452,000 after buying an additional 11 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares in the last quarter. Finally, Harwood Advisory Group LLC raised its stake in UnitedHealth Group by 0.8% in the first quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock valued at $309,000 after buying an additional 15 shares in the last quarter. 86.21% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Incorporated (NYSE:UNH) opened at 190.82 on Friday. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04. The company has a 50-day moving average price of $190.49 and a 200 day moving average price of $175.87. The company has a market cap of $184.50 billion, a PE ratio of 22.92 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. The company had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.96 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be given a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date of this dividend is Thursday, September 7th. UnitedHealth Group’s payout ratio is 35.13%.

TRADEMARK VIOLATION WARNING: This piece was originally published by BNB Daily and is owned by of BNB Daily. If you are viewing this piece on another site, it was illegally copied and republished in violation of US & international copyright law. The legal version of this piece can be read at https://www.baseball-news-blog.com/2017/08/19/catalyst-capital-advisors-llc-has-230000-stake-in-unitedhealth-group-incorporated-nyseunh-updated-updated.html.

A number of equities analysts have recently weighed in on UNH shares. Morgan Stanley upped their price objective on UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 28th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $187.00 price objective (up previously from $183.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $190.00 price objective on shares of UnitedHealth Group in a research note on Monday, July 10th. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and issued a $205.00 price objective (up previously from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Finally, Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday, May 19th. One research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $203.41.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares in the company, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. In the last three months, insiders sold 15,540 shares of company stock worth $2,873,320. 0.89% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply